CompletedPhase 2/3

Endothelial Cell Loss After Penetrating Keratoplasty

Egypt8 participantsStarted 2018-07-01

Plain-language summary

This work aimed at the assessment of corneal endothelial cell loss after toric ICL implantation for correction of myopia and astigmatism after penetrating keratoplasty.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * PKP for keratoconus, and then toric ICL was implanted after minimum of one year with stable refraction Exclusion Criteria: * Less than 18 and unable to give informed consent

What they're measuring

Refraction

Timeframe: 1 year

Visual acuity

Timeframe: 1 year

Intra-ocular pressure

Timeframe: 1 year

Trial details

NCT IDNCT04457063

SponsorAlexandria University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-06-01

View on ClinicalTrials.gov More Keratoconus trials